Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 11/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 6/20 | 0.44 |
| ▸ | CA2 | P00918 | 6/20 | 0.44 |
| ▸ | CA9 | Q16790 | 5/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8917741 | 0.92 | CA9 (0.52) | PTGS2PTGS1CA1CA2CA9 | |
| SCHEMBL9234798 | 0.92 | PTGS2 (0.52) | PTGS2PTGS1SMN1; SMN2CA1CA2 | |
| SCHEMBL8916189 | 0.92 | PTGS2 (0.52) | PTGS2PTGS1SMN1; SMN2CA1CA2 | |
| SCHEMBL8917527 | 0.90 | PTGS2 (0.45) | PTGS2PTGS1SMN1; SMN2 | |
| SCHEMBL8916244 | 0.83 | PTGS2 (0.42) | PTGS2PTGS1 | |
| SCHEMBL8920714 | 0.82 | PTGS2 (0.46) | PTGS2SMN1; SMN2CA1CA2CA9 | |
| SCHEMBL9229223 | 0.82 | PTGS2 (0.40) | PTGS2PTGS1 | |
| SCHEMBL9235122 | 0.81 | PTGS2 (0.54) | PTGS2PTGS1 | |
| SCHEMBL9233583 | 0.81 | PTGS2 (0.52) | PTGS2PTGS1CA1CA2CA9 | |
| SCHEMBL9231677 | 0.77 | CA1 (0.58) | PTGS2PTGS1CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5696143-A | ARTHRITIS THERAPY | G.D. SEARLE & CO. | 1997-12-09 | — | — | US | disclosed |